Dr. Ray has over two decades experience in biotech working at Gilead, Nimbus, Morphic and, most recently, serving as Chief Scientific Officer at Third Harmonic Bio. He has provided leadership for small molecule drug discovery, nonclinical development and translation across therapeutic areas contributing to numerous IND and successful worldwide registrational filings. Dr. Ray has authored >100 peer-reviewed articles, reviews, book chapters and letters to the editor in prestigious journals, including manuscripts published in Science and Nature. He is an inventor on >30 granted U.S. patents, including those supporting successful drugs Harvoni and Veklury.
Dr. Ray received his undergraduate degree in Molecular, Cellular and Developmental Biology from the University of California at Santa Cruz graduating with highest honors. He completed his graduate studies in the Pharmacology Department at Yale University. Dr. Ray was the recipient of the William H. Prusoff Young Investigator Lecture Award and the James R. Gillette Drug Metabolism and Disposition Best Paper Award.